Alphatec Holdings (ATEC) Stock Price
Alphatec Holdings Price
Over the last 19 years Alphatec Holdings grew revenue by 13.1% annually, reaching 764.16 M USD. For Alphatec Holdings, the net margin of -18.8% is up versus -58.8% a few years ago. The consensus 12-month price target for Alphatec Holdings is 15.00 USD, about 42.7% above where the stock trades today. Of 21 analysts, 19 rate the stock a buy — an overall Buy consensus.
Alphatec Holdings stock price
Alphatec Holdings business model & stock analysis
Frequently asked questions about Alphatec Holdings
The business model of Alphatec Holdings Inc revolves around providing innovative solutions for the treatment of spinal disorders. As a leading medical technology company, Alphatec specializes in developing and commercializing products and services focused on improving patients' quality of life. They offer a comprehensive portfolio of spinal implants, surgical products, and biologics that are designed to enhance surgical outcomes and minimize complications. Alphatec's commitment to research and development, strategic partnerships, and continuous innovation has positioned the company as a trusted provider in the orthopedic industry. With a patient-centric approach, Alphatec aims to address the evolving needs of healthcare professionals and patients alike.
Alphatec Holdings Inc is primarily active in the medical technology industry.
The main competitors of Alphatec Holdings Inc in the market include Medtronic, Zimmer Biomet Holdings, NuVasive, and Stryker Corporation.
Alphatec Holdings Inc is a renowned company with a rich history and background. Founded in 1990, it has established itself as a leading provider of innovative spine surgery solutions. With a focus on design, development, and promotion of medical devices, Alphatec continues to revolutionize the field of spinal surgeries. Over the years, the company has expanded its product portfolio, offering a comprehensive range of implants, instruments, and bio-materials. Alphatec Holdings Inc has consistently aimed to improve patient outcomes through advanced technology and surgical expertise, making it a trusted name in the industry. With its extensive experience and commitment to innovation, Alphatec Holdings Inc has become a top choice for healthcare professionals and patients worldwide.
Some significant milestones achieved by Alphatec Holdings Inc include a successful completion of a merger with Solas BioVentures, a significant increase in revenues, and the development of innovative surgical solutions. Alphatec Holdings Inc has also gained FDA clearance for various products, expanding its market reach. Additionally, the company has forged strategic partnerships and collaborations, facilitating the advancement of its technologies and expanding its product portfolio. Alphatec Holdings Inc continues to demonstrate a commitment to innovation, growth, and improving patient outcomes in the field of spinal surgery.
Alphatec Holdings Inc is primarily present in the United States of America.
Alphatec Holdings Inc represents values of innovation, collaboration, and excellence. The company is committed to advancing spinal fusion technology and providing innovative and quality solutions to patients and surgeons worldwide. With a mission to improve patients' lives, Alphatec Holdings Inc focuses on developing minimally invasive surgical techniques and products that result in enhanced clinical outcomes. Through strategic partnerships and a strong dedication to research and development, the company continuously drives advancements in spinal surgery. Alphatec Holdings Inc's corporate philosophy is centered around patient-centricity, continuous improvement, and delivering value to stakeholders.
Analysts currently set an average price target of 16.22 USD for the Alphatec Holdings stock (median: 15.00 USD), implying +54.3 % versus the latest price. The consensus is based on 21 analyst ratings.
21 analysts currently rate the Alphatec Holdings stock: 19 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Alphatec Holdings to generate revenue of 882.06 M USD and earnings per share of 0.33 USD.
Converted at the current exchange rate, the Alphatec Holdings share trades at 9.38 EUR (10.52 USD).
The Alphatec Holdings share (ATEC) is listed on 3 stock exchanges, including: NASDAQ (ATEC), Frankfurt (L1Z1.F), München (L1Z1.MU).
Alphatec Holdings Inc is a leading provider of innovative medical devices and instruments for spinal and neurosurgery. The company is divided into multiple business segments that focus on different aspects of the business. One of Alphatec's main business areas is the development and manufacturing of spinal systems. These products are used by orthopedic surgeons and neurosurgeons in surgeries to treat spinal injuries and disorders. The range includes implants, connecting elements, and instruments that enable surgeons to perform precise and effective procedures. Another important business segment of Alphatec is the development of technologies to support spinal and nervous system surgeries. This includes a wide range of products, such as imaging systems, nerve stimulators, and neuromonitoring devices. These technologies assist surgeons in performing surgical procedures more accurately and safely, thereby minimizing the risk of complications. Alphatec also has an extensive research and development department that continuously produces new products and technologies. In recent years, the company has developed several groundbreaking products, such as the Inlessis implant family, which offer significantly higher stability and effectiveness compared to conventional implants. To complement its offerings, Alphatec also provides a comprehensive range of education and training programs for surgeons and operating room personnel. These trainings help improve the knowledge and skills of medical professionals in the field of spinal surgery, thereby increasing their success rates. To drive its business forward, Alphatec has established a strong presence in several key markets. The company operates in over 50 countries worldwide and has a strong market position in North America, Europe, and Asia. Through targeted strategic partnerships and acquisitions, Alphatec is able to expand its reach and offerings. In summary, Alphatec Holdings Inc is an innovative provider of medical devices and instruments for spinal and neurosurgery. With its wide range of products, technologies, and trainings, the company has achieved a strong position in the market and is well-positioned for future growth.
The expected revenue of Alphatec Holdings is 882.06 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Alphatec Holdings is 49.02 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Alphatec Holdings is currently 32.19. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Alphatec Holdings stock.
The price-to-sales ratio (P/S) of Alphatec Holdings is currently 1.79. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Alphatec Holdings stock.
The Eulerpool Quality Score for Alphatec Holdings is 4/10.
The ISIN of Alphatec Holdings is US02081G2012. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Alphatec Holdings is A2AP5V. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Alphatec Holdings is ATEC. The ticker symbol is used to trade Alphatec Holdings shares on the stock exchange.
Alphatec Holdings stock
Alphatec Holdings Peer Group
Alphatec Holdings Ticker
Alphatec Holdings FIGI
All fundamentals and in-depth analysis of Alphatec Holdings
Our stock analysis for Alphatec Holdings stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alphatec Holdings. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.